Abstract Objective To study the association of single nucleotide polymorphisms (SNPs, rs223895 and rs223899) in TARC/CCL17 gene with Kawasaki disease (KD) and its clinical characteristics in Han children from Central China. Methods A case-control study was performed on 218 children with KD and 248 normal control children. The genotypes of SNPs (rs223895 and rs223899) in TARC/CCL17 gene were determined by polymerase chain reaction-restriction fragment length polymorphism. The association between the SNPs in TARC/CCL17 gene and the clinical characteristics of KD was assessed. Results There were significant differences in the genotype (CC, CT, TT) and allele frequencies of SNP rs223895 between children with KD and controls (P<0.05), and C allele was a risk factor (OR=1.397). However, no significant differences were found between the two groups in the genotype and allele frequencies of SNP rs223899. Compared with those with other genotypes (CT+TT) of SNP rs223895, patients with CC genotype had significantly lower hemoglobin (Hb) and albumin (Alb) levels (P<0.05) and a significantly higher erythrocyte sedimentation rate (ESR) (P <0.05). Conclusions The SNP rs223895 in TARC/CCL17 gene is associated with the susceptibility to KD, and C allele is a risk factor. Moreover, SNP rs223895 may influence the levels of Hb, Alb, and ESR.
LIU Fan,DING Yan,YIN Wei. Association of single nucleotide polymorphisms in TARC/CCL17 gene with Kawasaki disease and its clinical characteristics[J]. CJCP, 2015, 17(7): 668-671.
LIU Fan,DING Yan,YIN Wei. Association of single nucleotide polymorphisms in TARC/CCL17 gene with Kawasaki disease and its clinical characteristics[J]. CJCP, 2015, 17(7): 668-671.
Ogawa K, Morito H, Hasegawa A, et al. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS) [J]. J Dermatal Sci, 2013, 69(1): 38-43.
[4]
Lee C, Huang YH, Hsu Y, et al. TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease[J]. Pediatr Res, 2013, 74(5): 545-551.
[5]
Moriyama M, Hayashida JN, Yoyoshima T, et al. Cytokine/ chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome[J]. Clin Exp Immunol, 2012, 169(1): 17-26.
[6]
Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells towardantigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine[J]. Int Immunol, 1999, 11(1): 81-88.
[7]
Kataoka Y. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis[J]. J Dermatol, 2014, 41(3): 221-229.
[8]
Kuo HC, Wang CL, Liang CD, et al. Association of lower eosinophil-related T helper (Th2) cytokines with coronary artery lesions in Kawasaki disease[J]. Pediatr Allergy Immunol, 2009, 20(3): 266-272.
[9]
Webster RJ, Carter KW, Warrington NM, et al. Hospitalisation with infection, asthma and allergy in Kawasaki disease patients and their families: genealogical analysis using linked population data[J]. PLoS One, 2011, 6(11): e28004.
[10]
Maier E, Duschi A, Horejs-Hoeck J, et al. STAT6-dependent and -independent mechanisms in Th2 polarization[J]. Eur J Immonol, 2012, 42(11): 2827-2833.
[11]
Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22): 2606-2612.
